Filana Therapeutics, Inc. Operating Cash Flow
Filana Therapeutics, Inc. (FLNA) reported Operating Cash Flow of -$8.88 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-05-07
- Filana Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$8.88M.
- Filana Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$9.75M.
- Filana Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$6.22M.
- Filana Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-06-30 was -$4.95M.
- Filana Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$32.25M.
- Filana Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$116.93M.
- Filana Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$82.03M.
- Filana Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$77.51M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-03-31 | -$8.88M 10-Q · filed 2026-05-07 | -$18.63M derived: sum of 2 quarters · filed 2026-05-07 | -$24.85M derived: sum of 3 quarters · filed 2026-05-07 | -$29.79M derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | -$9.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$15.97M derived: sum of 2 quarters · filed 2026-03-12 | -$20.92M derived: sum of 3 quarters · filed 2026-03-12 | -$32.25M 10-K · filed 2026-03-12 |
| 2025-09-30 | -$6.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$11.17M derived: sum of 2 quarters · filed 2025-11-12 | -$22.50M 10-Q · filed 2025-11-12 | -$83.77M derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-06-30 | -$4.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$16.28M 10-Q · filed 2025-08-14 | -$77.55M derived: sum of 3 quarters · filed 2026-05-07 | -$95.84M derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-03-31 | -$11.34M 10-Q · filed 2026-05-07 | -$72.60M derived: sum of 2 quarters · filed 2026-05-07 | -$90.90M derived: sum of 3 quarters · filed 2026-05-07 | -$109.14M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$61.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$79.56M derived: sum of 2 quarters · filed 2026-03-12 | -$97.80M derived: sum of 3 quarters · filed 2026-03-12 | -$116.93M 10-K · filed 2026-03-12 |
| 2024-09-30 | -$18.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$36.54M derived: sum of 2 quarters · filed 2025-11-12 | -$55.66M 10-Q · filed 2025-11-12 | -$77.98M derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-06-30 | -$18.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$37.37M 10-Q · filed 2025-08-14 | -$59.68M derived: sum of 3 quarters · filed 2026-03-12 | -$86.21M derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-03-31 | -$19.13M 10-Q · filed 2025-05-08 | -$41.44M derived: sum of 2 quarters · filed 2026-03-12 | -$67.97M derived: sum of 3 quarters · filed 2026-03-12 | -$87.90M derived: sum of 4 quarters · filed 2026-03-12 |
| 2023-12-31 | -$22.32M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$48.85M derived: sum of 2 quarters · filed 2026-03-12 | -$68.77M derived: sum of 3 quarters · filed 2026-03-12 | -$82.03M 10-K · filed 2026-03-12 |
| 2023-09-30 | -$26.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$46.45M derived: sum of 2 quarters · filed 2024-11-07 | -$59.71M 10-Q · filed 2024-11-07 | -$81.03M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | -$19.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$33.18M 10-Q · filed 2024-08-08 | -$54.50M derived: sum of 3 quarters · filed 2025-03-03 | -$76.05M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | -$13.26M 10-Q · filed 2024-05-10 | -$34.58M derived: sum of 2 quarters · filed 2025-03-03 | -$56.13M derived: sum of 3 quarters · filed 2025-03-03 | -$67.24M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | -$21.32M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$42.87M derived: sum of 2 quarters · filed 2025-03-03 | -$53.98M derived: sum of 3 quarters · filed 2025-03-03 | -$77.51M 10-K · filed 2025-03-03 |
| 2022-09-30 | -$21.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$32.66M derived: sum of 2 quarters · filed 2023-11-07 | -$56.19M 10-Q · filed 2023-11-07 | -$64.18M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | -$11.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$34.64M 10-Q · filed 2023-08-03 | -$42.63M derived: sum of 3 quarters · filed 2024-02-28 | -$57.40M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | -$23.53M 10-Q · filed 2023-05-01 | -$31.52M derived: sum of 2 quarters · filed 2024-02-28 | -$46.28M derived: sum of 3 quarters · filed 2024-02-28 | -$51.42M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | -$7.99M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$22.75M derived: sum of 2 quarters · filed 2024-02-28 | -$27.89M derived: sum of 3 quarters · filed 2024-02-28 | -$30.20M 10-K · filed 2024-02-28 |
| 2021-09-30 | -$14.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | -$19.90M derived: sum of 2 quarters · filed 2022-11-07 | -$22.21M 10-Q · filed 2022-11-07 | -$23.38M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | -$5.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$7.45M 10-Q · filed 2022-08-04 | -$8.62M derived: sum of 3 quarters · filed 2023-02-28 | -$10.79M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | -$2.31M 10-Q · filed 2022-05-05 | -$3.48M derived: sum of 2 quarters · filed 2023-02-28 | -$5.65M derived: sum of 3 quarters · filed 2023-02-28 | -$6.49M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | -$1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$3.35M derived: sum of 2 quarters · filed 2023-02-28 | -$4.19M derived: sum of 3 quarters · filed 2023-02-28 | -$5.38M 10-K · filed 2023-02-28 |
| 2020-09-30 | -$2.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$3.01M derived: sum of 2 quarters · filed 2021-11-15 | -$4.21M 10-Q · filed 2021-11-15 | -$4.80M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | -$842.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$2.04M 10-Q · filed 2021-08-04 | -$2.63M derived: sum of 3 quarters · filed 2021-08-04 | -$3.35M derived: sum of 4 quarters · filed 2021-08-04 |
| 2020-03-31 | -$1.19M 10-Q · filed 2021-04-29 | -$1.78M derived: sum of 2 quarters · filed 2021-04-29 | -$2.51M derived: sum of 3 quarters · filed 2021-04-29 | -$3.10M derived: sum of 4 quarters · filed 2021-04-29 |
| 2019-12-31 | -$589.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23 | -$1.32M derived: sum of 2 quarters · filed 2021-03-23 | -$1.91M derived: sum of 3 quarters · filed 2021-03-23 | -$2.51M 10-K · filed 2021-03-23 |
| 2019-09-30 | -$730.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$1.32M derived: sum of 2 quarters · filed 2020-11-09 | -$1.93M 10-Q · filed 2020-11-09 | -$2.49M derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | -$591.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | -$1.20M 10-Q · filed 2020-08-12 | -$1.76M derived: sum of 3 quarters · filed 2020-08-12 | -$3.20M derived: sum of 4 quarters · filed 2020-08-12 |
| 2019-03-31 | -$604.00K 10-Q · filed 2020-05-06 | -$1.17M derived: sum of 2 quarters · filed 2020-05-06 | -$2.60M derived: sum of 3 quarters · filed 2020-05-06 | -$3.73M derived: sum of 4 quarters · filed 2020-05-06 |
| 2018-12-31 | -$565.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | -$2.00M derived: sum of 2 quarters · filed 2020-03-26 | -$3.13M derived: sum of 3 quarters · filed 2020-03-26 | -$4.77M 10-K · filed 2020-03-26 |
| 2018-09-30 | -$1.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-29 | -$2.56M derived: sum of 2 quarters · filed 2019-10-29 | -$4.21M 10-Q · filed 2019-10-29 | -$5.64M derived: sum of 4 quarters · filed 2019-10-29 |
| 2018-06-30 | -$1.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | -$2.77M 10-Q · filed 2019-08-12 | -$4.21M derived: sum of 3 quarters · filed 2019-08-12 | -$6.36M derived: sum of 4 quarters · filed 2019-08-12 |
| 2018-03-31 | -$1.64M 10-Q · filed 2019-05-02 | -$3.08M derived: sum of 2 quarters · filed 2019-05-02 | -$5.23M derived: sum of 3 quarters · filed 2019-05-02 | -$8.43M derived: sum of 4 quarters · filed 2019-05-02 |
| 2017-12-31 | -$1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | -$3.59M derived: sum of 2 quarters · filed 2019-03-29 | -$6.79M derived: sum of 3 quarters · filed 2019-03-29 | -$8.24M 10-K · filed 2019-03-29 |
| 2017-09-30 | -$2.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | -$5.35M derived: sum of 2 quarters · filed 2018-10-30 | -$6.80M 10-Q · filed 2018-10-30 | |
| 2017-06-30 | -$3.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-26 | -$4.65M 10-Q · filed 2018-07-26 | ||
| 2017-03-31 | -$1.45M 10-Q · filed 2018-05-09 | |||
| 2016-12-31 | -$12.23M 10-K · filed 2018-02-06 | |||
| 2013-09-30 | -$1.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-01 | -$3.62M derived: sum of 2 quarters · filed 2013-11-01 | -$5.49M 10-Q · filed 2013-11-01 | -$7.35M derived: sum of 4 quarters · filed 2013-11-01 |
| 2013-06-30 | -$1.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | -$3.67M 10-Q · filed 2013-08-01 | -$5.53M derived: sum of 3 quarters · filed 2013-08-01 | -$6.83M derived: sum of 4 quarters · filed 2013-11-01 |
| 2013-03-31 | -$1.87M 10-Q · filed 2013-04-24 | -$3.73M derived: sum of 2 quarters · filed 2013-04-24 | -$5.02M derived: sum of 3 quarters · filed 2013-11-01 | -$6.97M derived: sum of 4 quarters · filed 2013-11-01 |
| 2012-12-31 | -$1.85M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-08 | -$3.15M derived: sum of 2 quarters · filed 2013-11-01 | -$5.10M derived: sum of 3 quarters · filed 2013-11-01 | -$7.17M 10-K · filed 2013-02-08 |
| 2012-09-30 | -$1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-01 | -$3.25M derived: sum of 2 quarters · filed 2013-11-01 | -$5.32M 10-Q · filed 2013-11-01 | -$6.13M derived: sum of 4 quarters · filed 2013-11-01 |
| 2012-06-30 | -$1.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | -$4.02M 10-Q · filed 2013-08-01 | -$4.83M derived: sum of 3 quarters · filed 2013-08-01 | -$6.00M derived: sum of 4 quarters · filed 2013-08-01 |
| 2012-03-31 | -$2.07M 10-Q · filed 2013-04-24 | -$2.88M derived: sum of 2 quarters · filed 2013-04-24 | -$4.05M derived: sum of 3 quarters · filed 2013-04-24 | -$5.60M derived: sum of 4 quarters · filed 2013-04-24 |
| 2011-12-31 | -$809.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-08 | -$1.98M derived: sum of 2 quarters · filed 2013-02-08 | -$3.53M derived: sum of 3 quarters · filed 2013-02-08 | -$260.00K 10-K · filed 2013-02-08 |
| 2011-09-30 | -$1.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | -$2.72M derived: sum of 2 quarters · filed 2012-11-09 | $549.00K 10-Q · filed 2012-11-09 | -$2.79M derived: sum of 4 quarters · filed 2013-02-08 |
| 2011-06-30 | -$1.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | $1.72M 10-Q · filed 2012-08-02 | -$1.62M derived: sum of 3 quarters · filed 2013-02-08 | $1.81M derived: sum of 4 quarters · filed 2013-02-08 |
| 2011-03-31 | $3.27M 10-Q · filed 2012-05-08 | -$70.00K derived: sum of 2 quarters · filed 2013-02-08 | $3.36M derived: sum of 3 quarters · filed 2013-02-08 | |
| 2010-12-31 | -$3.34M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-08 | $91.00K derived: sum of 2 quarters · filed 2013-02-08 | -$143.00K 10-K · filed 2013-02-08 | |
| 2010-09-30 | $3.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | $3.20M 10-Q · filed 2011-11-03 | ||
| 2010-06-30 | -$234.00K 10-Q · filed 2011-08-04 | |||
| 2009-12-31 | -$14.69M 10-K · filed 2012-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |